The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Pennsylvania Court Makes it Possible to sue Negligent Drug Makers

Posted on January 27, 2014 by Larry Bodine
Legal news for consumers

Redux is a poisonous medicine made by Wyeth containing dexfenfluramine, which causes lung and heart disease.

In an important new decision favoring consumers, the Pennsylvania Supreme Court has ruled that pharmaceutical companies can be held responsible for negligently designing and selling a dangerous drug that is too harmful to be taken by anyone.

The case involved the prescription diet drug Redux, a poisonous medicine made by Wyeth containing dexfenfluramine that causes lung and heart disease. The lawsuit was brought on behalf of Ruth Lance, who took Redux and later died of pulmonary hypertension, Case. No 17 EAP 2011.

In September 1997, Wyeth and the FDA yanked Redux from the market in the United States. In the aftermath, consumers filed thousands of lawsuits asserting that the drugs caused injuries and deaths.

Before the landmark decision, drug makers were immune from responsibility if the Food and Drug Administration approved their drug. Pharmaceutical makers could be held liable only in rare cases if their drug had impurities or if there were deficient warnings.

Unreasonably dangerous

The lawsuit charges that Wyeth knew, or should have known, that the drug was so unreasonably dangerous and defective in design that it should never have been on the market. The lower courts had dismissed the case because the claim didn’t involve impurities or deficient warnings, before the Pennsylvania high court revived the case.

“[T]he public interest requires the holding of companies which make and sell drugs and medicine for use in the human body to a high degree of responsibility for any failure to exercise vigilance commensurate with the harm which would be likely to result …” the state supreme court said.

“[P]rimary responsibility for drug safety rests with the manufacturer, which has superior access to information about [its] drugs,” the court added. “Under Pennsylvania law, pharmaceutical companies violate their duty of care if they introduce a drug into the marketplace … with actual or constructive knowledge that the drug is too harmful to be used by anyone.”

Pharma Company Excuses

Importantly, the Pennsylvania court said that FDA approval does not give drug companies immunity. The court drew an “inference is that Wyeth failed to share relevant information with the federal agency.” The court added that the FDA has limited resources to monitor the thousands of drugs in the marketplace.

The drug companies argue that they need legal immunity because of the enormous cost of bringing a new drug to the market. But the court had no sympathy, saying the drug makers benefit from the federal patent system, which gives them exclusive profits from a patented drug for up to 20 years.

Wyeth also asserted that it was not responsible because a doctor is the actual person prescribing the drug. But the court pointed out the Wyeth did not convey the real dangers to doctors, and circumvented doctors with direct-to-consumer advertising about its drugs.

Ruth Lance died in 2004 and her mother has been pursuing the lawsuit since 2006. Now, finally, the case will get its day in court.


Get Legal News for Consumers delivered to your email box. Subscribe today completing the email form on the right side of this page.

Posted in Blog

Comments are closed.

News Categories

Subscribe to Blog and VFJ via Email

Enter your email address to subscribe to this blog, the Voice for Justice and receive notifications of new posts by email.

Read about other Top Jury Verdicts

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

Toyota Will Pay $180M to Settle Violations of the Clean-Air Act

The U.S. Department of Justice and U.S. Environmental Protection Agency (EPA) announced today that the United States has[Read More...]
Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Boeing's Insitu Will Pay $25M to Settle a Whistleblower Complaint About Used Drone Parts

Bingen, Wash.-based Insitu, a Boeing subsidiary, has agreed to pay $25 million to settle allegations that it used recycl[Read More...]
Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

Deutsche Bank Agrees to Settle Criminal and Civil Charges for $130M

DEUTSCHE Bank AG agreed to pay US$130 million to settle criminal and civil charges that it bribed foreign officials and manip[Read More...]
Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing Pays $2.5B to Settle Charges Tied to the 737 MAX Crashes

Boeing has agreed to pay just over $2.5 billion to resolve a federal charge of “criminal misconduct” for how its [Read More...]
Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

Texas Attorney General Seeks $43M in Google Antitrust Lawsuit

The mass exodus of Texas Attorney General Ken Paxton's top staff over accusations of bribery against their former boss has le[Read More...]

#LegalNews

@@TheNTLtop100

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.